// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Can we manage osteoporosis without patients ever seeing a consultant?

Joanne Fourmy - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoporosis

Hydroxyzine

Streamlining primary care referrals to an early inflammatory arthritis (EIA) clinic: distinguishing between patients with osteoarthritis and inflammatory arthritis

Ben M Jacobs - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Early inflammatory arthritis

N/A

Bringing patients into the referral process: an evaluation of pre-appointment questionnaires in a rheumatology new patient pathway

Winnie Chen - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Inflammatory Arthritis

N/A

Referral with a positive antinuclear antibody? Lessons from prospective triage and diagnosis in a single-centre service evaluation of 1,547 new rheumatology referrals

Natasha Cleaton - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Raynaud syndrome

N/A

Outcomes of enhanced triage of rheumatology referrals at a single point of access

Bethan Forgie - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

“Why do we have to lose this too?”: an exploration into the conversations around intimacy that individuals with Sjögren's syndrome have on an online forum

Jemma L McCready - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sjogren's syndrome

N/A

Evaluation of the 1st AStretch Digital Conference

William J Gregory - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Implementation of a regional trainee-led leadership and management programme for rheumatology trainees

Rosalind Benson - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

National competency framework for rheumatology nurse specialists

Diana I Finney - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Factors associated with educational needs in patients with inflammatory arthritis

Alice R Johnston - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

‘Best Foot Forward Workshops’: a novel supported self-management approach for foot health

Sue Connett - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identifying physical activity mobile applications for people with rheumatoid arthritis: a content analysis and quality appraisal

Lindsay Bearne - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Methadone hydrochloride

A survey of exercise preferences amongst a cohort of patients with spondyloarthritis

Amanda Owusu-Agyei - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Peripheral spondyloarthritis

N/A

Longitudinal patient reported outcome data collected from a smartphone app can map group level trajectories of disease activity over time

Philip D. H Hamann - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Therapists acceptability of delivering a psychologically informed gait rehabilitation intervention in early rheumatoid arthritis (GREAT): a qualitative interview study

Mandeep Sekhon - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Psychological and self-management support for people with systemic vasculitis or CTDs: a mixed methods study of health professionals’ perception of provision in Rheumatology and Nephrology departments in the UK

Joanna C Robson - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Prevalence of haemarthrosis and clinical impact on the musculoskeletal system in people with haemophilia in the United Kingdom: evaluation of UKHCDO and haemtrack patient reported data

Richard A Wilkins - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Hemophilia

N/A

Influenza vaccine uptake

Basil Noureldin - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Influenza

N/A

Developing a digital interface for outpatient rheumatology

Benjamin D Clarke - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Should standing consultations be offered throughout the NHS? An investigation into patient attitude towards standing consultations in a rheumatological department

Andrew Oliver - British Society for Rheumatology (BSR) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved